REPLIGEN CORPORATION -

Repligen Appoints Martin D. Madaus to Board of Directors

09 фев 2023 06:30:00 Источник Nasdaq GlobeNewswire

Repligen to Report Fourth Quarter and Full Year 2022 Financial Results

08 фев 2023 06:30:00 Источник Nasdaq GlobeNewswire

Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare Conference

03 янв 2023 06:30:00 Источник Nasdaq GlobeNewswire

Repligen Corporation to Present at Upcoming Investor Conferences

08 ноя 2022 06:30:00 Источник Nasdaq GlobeNewswire

Repligen Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance

01 ноя 2022 06:30:01 Источник Nasdaq GlobeNewswire

Repligen Extends and Expands Long-Term Supply Agreement with Purolite for Affinity Ligands

01 ноя 2022 06:00:01 Источник Nasdaq GlobeNewswire

Repligen to Report Third Quarter 2022 Financial Results

12 окт 2022 06:30:00 Источник Nasdaq GlobeNewswire

Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement

19 сен 2022 15:01:00 Источник Nasdaq GlobeNewswire

Repligen To Host Investor Day 2022

24 авг 2022 06:30:00 Источник Nasdaq GlobeNewswire

Repligen Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 Financial Guidance

02 авг 2022 06:30:01 Источник Nasdaq GlobeNewswire

Repligen to Report Second Quarter 2022 Financial Results

19 июл 2022 06:30:00 Источник Nasdaq GlobeNewswire

Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors

26 май 2022 15:30:00 Источник Nasdaq GlobeNewswire

Repligen Corporation to Present at Upcoming Investor Conferences

25 май 2022 06:30:00 Источник Nasdaq GlobeNewswire

Repligen Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance

27 апр 2022 06:30:01 Источник Nasdaq GlobeNewswire

Repligen to Report First Quarter 2022 Financial Results

13 апр 2022 06:30:00 Источник Nasdaq GlobeNewswire

Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum

18 мар 2022 06:30:00 Источник Nasdaq GlobeNewswire

Repligen Reports Fourth Quarter and Full Year 2021 Financial Results

17 фев 2022 06:30:01 Источник Nasdaq GlobeNewswire

Repligen Launches AAV Affinity Resins for Gene Therapy Purification

15 фев 2022 06:30:00 Источник Nasdaq GlobeNewswire

Repligen Corporation to Present at 11th Annual SVB Leerink Healthcare Conference

11 фев 2022 06:30:00 Источник Nasdaq GlobeNewswire

Repligen to Report Fourth Quarter and Full Year 2021 Financial Results

03 фев 2022 08:30:09 Источник Nasdaq GlobeNewswire